5-Amino-1MQ (Chloride) 50mg (10 Vials/kit): Selective NNMT Inhibitor for Metabolic Research
In obesity and metabolic disease models, NNMT expression is significantly upregulated in fat tissue, resulting in metabolic slowing and reduced mitochondrial biogenesis. By selectively binding the active site of NNMT, 5-Amino-1MQ blocks the methyl transfer cascade, preserving both $\text{NAD}^+$ and $\text{SAM}$ intracellular reserves. This preservation stimulates sirtuin-1 ($\text{SIRT1}$) signaling, downregulates lipogenic gene expression, and enhances basal cellular energy expenditure without activating central nervous system adrenergic receptors or inducing cardiovascular stress.
Maintaining precise analytical concentration across cellular incubation and animal metabolic assays requires reliable bulk packaging. The 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) configuration supplies a total yield of 500mg active material distributed across ten individual 50mg USP Type I borosilicate glass vials. Freeze-dried under sterile vacuum conditions, each vial contains a uniform, highly stable lyophilized chloride salt cake. This modular multi-vial system allows laboratory personnel to reconstitute only the working stock required for immediate experimental protocols, keeping remaining kit stock preserved in deep freeze stasis and avoiding structural loss caused by repeated freeze-thaw cycles.
NNMT Inhibition Mechanisms, NAD+ Preservation, and Technical Specifications
The primary research interest in 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) stems from its direct modulation of methyl donor pathways and cellular energy sensing networks:
-
Selective NNMT Enzymatic Blockade: Acts as a competitive inhibitor of Nicotinamide N-methyltransferase with low micromolar affinity ($\text{IC}_{50} \approx 2.1\ \mu\text{M}$), effectively preventing the conversion of nicotinamide to 1-MNA.
-
Intracellular NAD+ Accumulation: Blocks the enzymatic siphon of nicotinamide, directly augmenting intracellular $\text{NAD}^+$ pools to boost mitochondrial oxidative phosphorylation and ATP generation.
-
SIRT1 & AMP-Kinase Activation: Elevated $\text{NAD}^+$ levels stimulate $\text{SIRT1}$ deacetylase activity, triggering peroxisome proliferator-activated receptor gamma coactivator 1-alpha ($\text{PGC-1}\alpha$) and activating $\text{AMPK}$ pathways that govern fatty acid oxidation.
-
Adipocyte Shrinkage & Anti-Lipogenic Activity: Reduces fat cell volume and prevents lipid accumulation in diet-induced obesity models without impacting food intake or central neural satiety centers.
-
Ultra-High Chemical Purity ($\ge$99.0%): Synthesized via precision organic synthesis and purified using preparative High-Performance Liquid Chromatography (HPLC) to guarantee freedom from heavy metals and unreacted intermediates.
| Biochemical / Technical Parameter | Technical Profile for 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) |
| Product Identifier | 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) |
| Chemical Name | 5-amino-1-methylquinolinium chloride |
| CAS Registry Number | 42464-96-0 (Salts/Derivatives) |
| Molecular Formula | $\text{C}_{10}\text{H}_{11}\text{ClN}_2$ |
| Molecular Mass | Approximately 194.66 g/mol |
| Chemical Purity | $\ge$99.0% (Verified by analytical HPLC peak integration) |
| Physical Appearance | Yellow to orange-yellow, sterile lyophilized powder cake |
| Package Configuration | 10 USP Type I Borosilicate Glass Vials per Kit (50mg per vial) |
| Primary Research Domains | NNMT inhibition, $\text{NAD}^+$ salvage pathways, adipocyte metabolism, SIRT1 signaling |
Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols
Achieving reproducible, publication-grade results when working with 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) requires strict adherence to standardized laboratory preparation and climate-controlled storage protocols. As a salt compound, 5-Amino-1MQ exhibits high aqueous solubility, but reconstituted solutions must be protected from light and moisture to prevent chemical degradation.
Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:
-
Thermal Balancing: Allow the frozen 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) vial to reach ambient room temperature prior to solvent introduction to prevent condensation inside the glass container.
-
Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to dry completely.
-
Solvent Introduction: Using a sterile syringe with a fine-gauge needle, draw the desired volume of Dimethyl Sulfoxide (DMSO), Sterile Normal Saline (0.9% NaCl), or Deionized Water. Direct the stream against the inner glass wall so it trickles gently over the lyophilized powder.
-
Complete Dissolution: Swirl the vial gently until the compound is completely dissolved into a clear solution. Avoid excessive agitation, as high-shear mixing can induce micro-bubbling.
-
Aliquoting Strategy: For multi-week testing protocols, divide reconstituted solution into sterile, single-use microcentrifuge tubes under light-protected conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.
| Operational Storage Phase | Recommended Environmental Conditions | Bioactive Stability Duration |
| Unopened Lyophilized Kit | Deep Freeze at -20°C to -80°C (Protected from light and moisture) | 24 to 36 Months |
| Unopened Short-Term Storage | Refrigerated at 2°C to 8°C (Sealed dark storage container) | Up to 90 Days |
| Reconstituted Solution | Refrigerated at 2°C to 8°C (In DMSO or Saline, light-protected) | Up to 21–28 Days |
| Frozen Liquid Aliquots | Deep Freeze at -20°C or colder (Single freeze-thaw max) | Up to 6 Months |
Batch Quality Documentation & Traceability: Every production lot of 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm purity exceeding 99.0%, while Nuclear Magnetic Resonance (NMR) spectroscopy and Mass Spectrometry (MS) confirm precise chemical structure. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.
Strict Regulatory & Research Compliance Statement: 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. 5-Amino-1MQ (Chloride) 50mg (10 Vials/kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.




Reviews
There are no reviews yet.